Abstract
Mammographic screening is effective in reducing mortality from breast cancer. The
issue is not whether mammography is effective, but whether the false positive rate
and false negative rates can be reduced. This review will discuss controversies including
the reduction in breast cancer mortality, overdiagnosis, the ideal screening candidate,
and the optimal imaging modality for breast cancer screening. The article will compare
and contrast screening mammography, tomosynthesis, whole-breast screening ultrasound,
magnetic resonance imaging, and molecular breast imaging. Though supplemental imaging
modalities are being utilized to improve breast cancer diagnosis, mammography still
remains the gold standard for breast cancer screening.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical ImagingAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Breast cancer estimated incidence mortality and prevalence worldwide in 2012.(Available from:)
- Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.Radiology. 2011; 260: 658-663
- The benefits and harms of breast cancer screening: an independent review.Lancet. 2012; 380: 1778-1786
- Screening for breast cancer with mammography.The Cochrane Library, 2013
- Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.Lancet. 1985; 325: 829-832
- Ten-to fourteen-year effect of screening on breast cancer mortality.J Natl Cancer Inst. 1982; 69: 349-355
- Effect of three decades of screening mammography on breast-cancer incidence.N Engl J Med. 2012; 367: 1998-2005
- Association of health literacy with adherence to screening mammography guidelines. Presented at the San Antonio Breast Cancer Symposium. 2011
- Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older.Ethn Dis. 2003; 13: 477-484
- Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.Radiology. 1998; 209: 511-518
- Diagnostic performance of digital versus film mammography for breast-cancer screening.Obstet Gynecol Surv. 2006; 61: 1773-1783
- Screening for breast cancer: US Preventive Services Task Force recommendation statement.Ann Intern Med. 2009; 151: 716-726
- Biasing the interpretation of mammography screening data by age grouping: nothing changes abruptly at age 50.Breast J. 1998; 4: 139-145
- Effect of screening mammography on breast-cancer mortality in Norway.N Engl J Med. 2010; 363: 1203-1210
- Point: The New England Journal of Medicine article suggesting overdiagnosis from mammography screening is scientifically incorrect and should be withdrawn.J Am Coll Radiol. 2013; 10: 317-319
- The mammographic screening trials: commentary on the recent work by Olsen and Gøtzsche.J Surg Oncol. 2002; 81: 159-162
- Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.BMJ. 2014; 348https://doi.org/10.1136/bmj.g366
- Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.CMAJ. 1992; 147: 1459-1476
- Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.CMAJ. 1992; 147: 1477-1488
- Pan-Canadian study of mammography screening and mortality from breast cancer.J Natl Cancer Inst. 2014; 106: dju261https://doi.org/10.1093/jnci/dju261
- Screening for breast cancer: an update for the US Preventive Services Task Force.Ann Intern Med. 2009; 151: 727-737
- Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet.J Med Screen. 2012; 19: 5-13
- Real and artificial controversies in breast cancer screening.Breast Cancer Manag. 2013; 2: 519-528
- Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.J Med Screen. 2012; 19: 42-56
- Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.BMJ. 2009; 339: b2587
- Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.Ann Intern Med. 2012; 156: 491-499
- A reality check for overdiagnosis estimates associated with breast cancer screening.J Natl Cancer Inst. 2014; 106: dju315
- Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time.Breast Cancer Res. 2013; 15: R41
- Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.Eur J Cancer. 2003; 39: 1746-1754
- US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey.BMJ. 2000; 320: 1635-1640
- The randomized trials of breast cancer screening: what have we learned?.Radiol Clin N Am. 2004; 42: 793-806
- Effectiveness of population‐based service screening with mammography for women ages 40 to 49 years.Cancer. 2011; 117: 714-722
- Effect of screening and adjuvant therapy on mortality from breast cancer.N Engl J Med. 2005; 353: 1784-1792
- Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.Br J Cancer. 2011; 104: 1656-1663
- Breast‐cancer screening with mammography in women aged 40–49 years.Int J Cancer. 1996; 68: 693-699
- Screening mammography in women less than age 50 years.Curr Opin Obstet Gynecol. 2012; 24: 38-43
- Positive predictive value of screening mammography by age and family history of breast cancer.JAMA. 1993; 270: 2444-2450
- Cancer mortality in the 50–69 year age group before and after screening.J Med Screen. 2010; 17: 159-160
- Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark.Eur J Cancer. 2003; 39: 1783-1793
- Effect of mammographic service screening on stage at presentation of breast cancers in Sweden.Cancer. 2007; 109: 2205-2212
- SEER cancer statistics review, 1975–2007.National Cancer Institute, Bethesda, MD2010: 7
- Surveillance, Epidemiology, and End Results (SEER) Program.(Available from:)
- Cancer statistics, 2006.CA Cancer J Clin. 2006; 56: 106-130
- Breast cancer screening using tomosynthesis in combination with digital mammography.JAMA. 2014; 311: 2499-2507
- Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program.Radiology. 2013; 267: 47-56
- Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.Lancet Oncol. 2013; 14: 583-589
- Implementation of breast tomosynthesis in a routine screening practice: an observational study.Am J Roentgenol. 2013; 200: 1401-1408
- Characterization of breast lesions: comparison of digital breast tomosynthesis and ultrasonography.Korean J Radiol. 2015; 16: 229-238
- Ultrasound is now better than mammography for the detection of invasive breast cancer.Am J Surg. 2004; 188: 381-385
- Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer 1.Radiology. 2004; 233: 830-849
- Using sonography to screen women with mammographically dense breasts.Am J Roentgenol. 2003; 181: 177-182
- Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue 1.Radiology. 2001; 221: 641-649
- Occult cancer in women with dense breasts: detection with screening US–diagnostic yield and tumor characteristics.Radiology. 1998; 207: 191-199
- Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations 1.Radiology. 2002; 225: 165-175
- Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density.Am J Roentgenol. 2003; 180: 1675-1679
- Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients 1.Radiology. 2002; 224: 569-576
- Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts.Eur Radiol. 2010; 20: 734-742
- Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.JAMA. 2008; 299: 2151-2163
- Improved breast cancer detection in asymptomatic women using 3D-automated breast ultrasound in mammographically dense breasts.Clin Imaging. 2013; 37: 480-486
- Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: The SomoInsight Study.Radiology. 2014; 274: 663-673
- The Connecticut experiment: the role of ultrasound in the screening of women with dense breasts.Breast J. 2012; 18: 517-522
- American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.CA Cancer J Clin. 2007; 57: 75-89
- Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.J Clin Oncol. 2005; 23: 8469-8476
- Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.N Engl J Med. 2004; 351: 427-437
- Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).Lancet. 2005; 365: 1769-1778
- Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?.Eur Radiol. 2007; 17: 873-887
- Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.JAMA. 2004; 292: 1317-1325
- Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer 1.Radiology. 2005; 237: 274-280
- Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer 1.Radiology. 2008; 247: 651-657
- Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade.Breast. 2014; 85: e-212-e216
- Breast‐specific gamma imaging with 99mTc‐Sestamibi and magnetic resonance imaging in the diagnosis of breast cancer—a comparative study.Breast J. 2007; 13: 465-469
Article Info
Publication History
Published online: June 03, 2015
Accepted:
May 26,
2015
Received:
March 28,
2015
Identification
Copyright
© 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
